Beranda › Aterosklerosis › California › Torrance
Uji klinis Aterosklerosis di Torrance, CA
5 studi untuk Aterosklerosis mencari peserta di lokasi sekitar Torrance (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Menerima pesertaFase 3
- UCLA South Bay Endocrinology, Torrance
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Menerima pesertaFase 2
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Menerima pesertaFase 3
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Menerima pesertaFase 3
- Research Site, Torrance
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
Menerima pesertaFase 4
- Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), Torrance
Uji klinis Aterosklerosis di kota lain
- Boston, MA10 studi
- Houston, TX10 studi
- Washington, DC9 studi
- Orlando, FL8 studi
- Arlington, VA8 studi
- Hialeah, FL8 studi
- Durham, NC7 studi
- Memphis, TN7 studi
- Dallas, TX7 studi
- Miami, FL7 studi
- Las Vegas, NV7 studi
- Minneapolis, MN6 studi
Studi lain di Torrance
- Kanker Paru Non-Sel Kecil11 studi
- Obesitas9 studi
- Kelebihan Berat Badan9 studi
- Kanker Payudara9 studi
- Kanker Kandung Kemih7 studi
- Kanker Paru7 studi
- Penyakit Kardiovaskular7 studi
- Skizofrenia6 studi
- Gagal Jantung5 studi
- Kanker Metastatik4 studi
- Kanker Kolorektal4 studi
- Penyakit Arteri Koroner4 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.